Alexis Borisy
Life Sciences Entrepreneur and Investor
Greater Boston
Overview
Work Experience
Co-Founder & Chairman
2022 - Current
Curie.Bio is a founder-focused seed-stage venture capital firm.
Board Member
2022
Co-Founder
2022
Founder & Executive Chairman
2021
Founder, Chairman, and CEO
2020 - 2021
Co-Founder and Chairman
2016
Co-Founder and CEO
2016 - 2017
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Raised $1,400,000,000.00 from Nextech Invest.
Chairman Of The Board
2017
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Raised $351,000,000.00 from Casdin Capital, RA Capital Management, Woodline Partners, Boxer Capital, EcoR1 Capital, Surveyor Capital, Farallon Capital Management, Avoro Capital Advisors, Gilead Sciences and Samsara BioCapital.
Founding Investor & Board Member
2014
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Raised $2,004,400,000.00 from Nextech Invest, Boxer Capital, Schroder Adveq, Cormorant Capital, Casdin Capital, Vivo Capital, Biotechnology Value Fund, Deerfield Capital Management, Third Rock Ventures and Fidelity.
Co-Founder and Director
2010
Interim CEO
2013 - 2014
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Raised $2,367,800,000.00 from Royalty Pharma, Sixth Street and Cowen Investment Management.
Board Of Directors
2019 - 2021
Partner
2010 - 2019
Education
Master's degree
1993 - 1995
Bachelor's degree
1989 - 1993